CYTOAGENTS
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.
CYTOAGENTS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2018-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.cytoagents.com
Total Employee:
1+
Status:
Active
Total Funding:
10.21 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Font Awesome
Similar Organizations
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Walden Biosciences
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Founder
Investors List
Innovation Works
Innovation Works investment in Seed Round - CytoAgents
National Institutes of Health
National Institutes of Health investment in Grant - CytoAgents
Innovation Works
Innovation Works investment in Seed Round - CytoAgents
AlphaLab Health
AlphaLab Health investment in Seed Round - CytoAgents
Richard King Mellon Foundation
Richard King Mellon Foundation investment in Grant - CytoAgents
National Institutes of Health
National Institutes of Health investment in Grant - CytoAgents
EQx Fund
EQx Fund investment in Convertible Note - CytoAgents
Innovation Works
Innovation Works investment in Seed Round - CytoAgents
Boston Harbor Angels
Boston Harbor Angels investment in Angel Round - CytoAgents
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-07 | CytoAgents Announces Appointment of New Chief Medical Officer |
Official Site Inspections
http://www.cytoagents.com
- Host name: 219.112.62.166.host.secureserver.net
- IP address: 166.62.112.219
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "CytoAgents"
CytoAgents - Crunchbase Company Profile & Funding
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.See details»
About CytoAgents
CytoAgents targets cytokines specifically active in CRS disease, allowing treatment without disrupting normal immune system mechanisms.See details»
CytoAgents Company Profile | Management and Employees List
CytoAgents Profile and History CytoAgents is a clinical-stage biotechnology company focused …See details»
CytoAgents Company Profile 2024: Valuation, Funding & Investors …
Information on valuation, funding, cap tables, investors, and executives for CytoAgents. Use …See details»
CytoAgents, Inc - LinkedIn
CytoAgents is a clinical stage biotechnology company focused on the development of …See details»
Cytoagents - Company Profile - Tracxn
Nov 27, 2024 Cytoagents - Provider of pharmaceutical products for the treatment of viral …See details»
CytoAgents - Funding, Financials, Valuation & Investors
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, …See details»
Cytoagents, Inc. - VentureRadar
CytoAgents is a clinical-stage biotechnology company focused on the development of …See details»
CytoAgents Announces FDA Acceptance of IND Application for …
May 11, 2023 CytoAgents is a privately held, clinical-stage biotechnology company focused …See details»
CytoAgents, Inc. | Life Sciences PA - Default Site
CytoAgents is a clinical stage biotechnology company focused on the development of …See details»
CytoAgents | Pittsburgh, PA, USA Startup - gust.com
CytoAgents is a clincal-stage biotech company creating a platform to treat viral epidemics and …See details»
CytoAgents Company Profile - Office Locations, Competitors, …
CytoAgents has 5 employees at their 1 location. See insights on CytoAgents including office …See details»
CYTOAGENTS’ TERESA WHALEN SELECTED FOR COMPETITIVE EY …
Nov 8, 2021 EY announced today that Teresa Whalen, CEO of CytoAgents, a biotech …See details»
CytoAgents - Products, Competitors, Financials, Employees, …
CytoAgents is a clinical-stage biotechnology company focused on developing treatments for …See details»
CytoAgents - Contacts, Employees, Board Members, Advisors
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, …See details»
Our Team | Teresa Whalen | CytoAgents
Led by CEO Teresa Whalen, CytoAgents is comprised of seasoned business leaders and …See details»
CytoAgents Receives Second Round of NIH Funding to Accelerate …
Mar 10, 2021 CytoAgents announced today that it has received a $2 million NIH grant to …See details»
CytoAgents’ Phase 1 Trial Results Show “Cytokine ... - Business Wire
Aug 10, 2021 CytoAgents is a privately held, clinical-stage biotechnology company focused …See details»
Press Release - CytoAgents
Mar 10, 2021 CytoAgents Inc. (the Company), a clinical-stage biotechnology company, …See details»